We report a 29-year-old lady who developed confusion, agitation and seizure after the ingestion of a selfmixture of 3 grams of lidocaine with antacid for treatment of dyspepsia. She developed two episodes of seizure requiring diazepam, propofol and intubation .There was no significant cardiac toxicity and she was discharged on day 3. This is the first reported adult case of seizure in the literature after intentional ingestion of lidocaine for treatment of dyspepsia. The use of local anaesthetic in gastrointestinal cocktail for dyspepsia and its safety are highlighted. Advances in the management of local anaesthetic overdose are also discussed. (Hong Kong j.emerg.med. 2009;16:41-45) 29 3
Introduction
Local anaesthetics have long been added to antacid for gastric pain relief. Oxethazaine is the commonest local anaesthetic in the formulary of antacid mixtures such as Gastrocaine and Mucaine. However, other local anaesthetics like lidocaine may be intentionally added to antacid mixtures by general practitioners or emergency physicians in order to improve the efficacy of pain relief. Lidocaine belongs to the amide group of local anaesthetics. It is also used as a type 1b antiarrhythmic agent. It is rapidly absorbed from the gastrointestinal tract with peak plasma level within 30 to 60 minutes. After ingestion, lidocaine undergoes extensive first-pass hepatic metabolism with a bioavailability of about 35%. 1 This may cause a false impression of general safety of its use as an oral agent. Published reports of toxicity of lidocaine largely involved parenteral therapy. [2] [3] [4] [5] We report a case of central nervous system (CNS) lidocaine toxicity after the ingestion of a self-mixture of lidocaine and antacid.
Case report
A 29-year-old lady presented to the emergency department in December 2006 with agitation and confusion after taking an "antacid" self-mixture. She was the wife of a private general practitioner and was working as a nurse in her husband's clinic. Her past health was good otherwise and she had no history of epilepsy. Despite a history of doxycycline-induced oesophageal ulcer, she took doxycycline for acne two days before the incident. She felt some chest discomfort after taking the drug and took a whole cup of an "antacid" self-mixture in an attempt to relieve the pain. According to her husband, she had mixed mucin with 3 grams of lidocaine. She felt dizzy 75 minutes after the ingestion and was found confused by her husband subsequently. There was no evidence of suicidal intention.
On arrival at our emergency department, she was agitated and had confused speech with Glasgow Coma Scale score of 14/15. Her initial blood pressure was 144/69 mmHg with a pulse rate at 144 per minute. Her temperature was 37.9 o C. Her respiratory rate was 22 per minute with a SpO 2 of 96% on 2 litres of oxygen. The Hemostix was 6.5 mmol/L. Twitching movement with muscle spasm was noticed at her limbs. The pupils were 4 mm in diameter, equal and reactive and no focal neurological deficit was found. Her skin was normal. Bowel sound was normal and the bladder was not palpable. The electrocardiogram showed sinus tachycardia with a heart rate of 139 beats per minute, and QTc of 0.89 sec (Figure 1 ).
She was admitted to the intensive care unit (ICU) for further management. Shortly after arrival at the ICU, she developed two episodes of brief generalised convulsion with each episode lasting for around 30 seconds, and 5 mg of intravenous diazepam was administered. She was then intubated for airway protection. Propofol infusion was given and activated charcoal was administered via a Ryle's tube after intubation. No malignant arrhythmia was detected during obser vation. Lidocaine and doxycycline were detected in her blood and urine. Arterial blood gas and renal function tests including electrolytes were unremarkable. She remained seizure-free and was successfully extubated the next day. She remained stable and was discharged three days after admission.
Discussion
Dyspepsia and gastric pain are common presenting symptoms to both general practitioner clinic and emergency department. Treating dyspepsia with a gastrointestinal (GI) cocktail, a mixture of lidocaine and antacid with or without antispasmodic, is one commonly prescribed treatment in the emergency department of some countries. 6 Although it is not a common practice in emergency departments of Hong Kong, some private practitioners may add lidocaine to antacid mixture, hoping that its local anaesthetic effect to the gastroesophageal mucosa can enhance the pain relieving efficacy. However, there is a question about its evidence base and safety of such practice.
Welling and Watson did a randomised control trial in 76 patients in an urban emergency department with symptoms consistent with dyspepsia. 7 Patients were randomised to receive antacid alone (Mylanta II) or GI cocktail (Mylanta II and 15 ml 2% viscous lidocaine). Pain was measured on an 11 cm scale before, and 30 minutes after treatment. They showed a single dose of antacid and viscous lidocaine provided a statistically significant improvement in pain at 30 minutes. However, interviewers were not blinded to study patients which might lead to bias and skewed their finding that the GI cocktail was more effective. 6 Another prospective double-blind randomised trial was done by Berman et al in 120 adult patients. 8 Patients were randomised to receive antacid alone, Donnatal (antispasmodic)-antacid or Donnatal-viscous lidocaine (10 ml 2%)-antacid. Pain was measured on a visual analogue scale. They showed no statistically significant difference in pain relief among the three groups.
In both studies, no significant adverse effects were noted with the addition of a single dose of lidocaine. However, significant toxicity is possible with large or multiple oral doses.
Our case is the only adult case reported in the literature to have seizure after intentional oral ingestion of lidocaine for the treatment of dyspepsia. Oral ingestion of 5 to 25 ml of 2% viscous lidocaine have resulted in seizure in children. [9] [10] [11] [12] One adult case report of oral lidocaine toxicity described accidental ingestion of 30 ml 4% topical lidocaine (1.2 grams) in a 74-yearold woman. 13 She was given a cup of topical lidocaine to gargle the back of the throat and was supposed to spit it out before the elective dilatation of her oesophageal stricture. However, she did not completely understand the instructions and swallowed the entire amount. She became agitated and confused about an hour after the ingestion. The symptoms completely resolved around four hours post-ingestion. No seizure was detected.
Lidocaine toxicity is generally referable to the neurologic, cardiovascular and hematologic systems. Systemic toxicity of lidocaine correlates with the plasma concentration. It was demonstrated that CNS toxicity develops at a lower plasma concentration than is needed to produce cardiac toxicity. Plasma concentrations of 5-10 µg/ml may be associated with marked CNS toxicity and higher level may produce coma, apnoea and cardiovascular collapse. [12] [13] [14] [15] The initial symptoms include tinnitus, lightheadedness, circumoral numbness, agitation and confusion. An initial physiological response with tachycardia and hypertension may occur. Severe cases may progress to seizure, coma, respiratory depression, bradycardia, ventricular dysrhythmia and asystole. Asystole has been reported in patients who received unintentional intravenous injections of 800-1000 mg of lidocaine. [2] [3] [4] [5] Seizure occurred prior to cardiac arrest in most patients. Thus, CNS toxicity provides a warning sign to cardiac toxicity. Early recognition of potential cardiac toxicity is important because if it goes unrecognised for any interval, it is more difficult to resuscitate. The earliest signs of cardiac toxicity are ECG changes which include prolonged PR, QRS and QT intervals. Subsequently, it may progress to bradycardia, atrioventricular and intraventricular blocks, ventricular dysrhythmia and cardiovascular collapse that are often refractory to treatment. The level causing cardiovascular collapse to CNS toxicity ratio (CC/CNS) has been estimated in animal studies. 16 Local anaesthetics with higher potency and lipophilicity such as bupivacaine have a lower CC/CNS ratio as compared with that of lidocaine (3 vs. 7). Therefore, bupivacaine toxicity can occur with few premonitory symptoms of CNS excitation.
The mainstay of management in lidocaine or other local anaesthetic toxicity is supportive treatment to prevent hypoxia, acidosis and hyperkalaemia which may enhance the toxicity, especially cardiac toxicity. Gastric decontamination is of limited value because of rapid absorption after ingestion. Benzodiazepine and barbiturates can be used to control local anaestheticinduced seizure. However, they may exacerbate circulatory and respiratory depression. Propofol was found to be as effective as thiopental in the treatment of bupivacaine-induced seizure in rats and also has been used successfully to stop seizure in patients with lidocaine toxicity. 17, 18 However, it should be used cautiously in patients with local anaesthetic toxicity because it typically lowers blood pressure and may cause significant bradydysrhythmias and even asystole. Therefore, it is contraindicated in local anaesthetic toxicity with cardiovascular compromise. It is also proposed that propofol's effect in bupivacaine toxicity may be due to the lipid component of the propofol preparation in which 10% lipid is present. 19 
LipidRescue
TM resuscitation refers to the use of an intravascular infusion of a lipid emulsion to treat severe, systemic drug toxicity or poisoning. 20 It has not only been shown to be effective in treating local anaesthetic toxicity but it has also been proposed as a treatment modality for poisoning with other lipophilic agents in general recently. Animal trials showed encouraging results of lipid infusion in treating serious cardiac toxicity induced by bupivacaine. 21 There are also at least two human case reports of successful resuscitation using Intralipid infusion for cardiac arrest induced by local anaesthetics. 22, 23 The proposed mechanism is that the lipophilic local anaesthetic agent is removed from affected tissues by partitioning into plasma lipid phase created by the infusion and this mechanism is the so called "lipid sink" mechanism. 24 There was a case report describing the successful treatment of refractory cardiac arrest caused by overwhelming bupropion overdose with lipid infusion. 25 
Conclusion
Due to the lack of evidence supporting its use and its potential toxicity, the addition of lidocaine to antacid for treatment of dyspepsia is not recommended. However, if it is to be given, it should be given in a single oral dose of less than 300 mg. Commercial preparations with local anaesthetic like oxethazaine may be the alternative. Seizure is a warning sign for subsequent cardiac toxicity which can be lethal.
Patients with local anaesthetic toxicity should be monitored closely for cardiac complication which is a common cause of death if seizure occurs. More research is necessary for the potential use of Intralipid in patients with cardiac toxicity after taking local anaesthetic.
